Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) General Information

Description

License for ISIS-FXIRx, an experimental anticoagulant drug of a pharmaceutical company, based in Carlsbad, California.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2855 Gazelle Court
  • Carlsbad, CA 92010
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Bayer
Corporate Office
  • 2855 Gazelle Court
  • Carlsbad, CA 92010
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug)‘s full profile, request access.

Request a free trial

Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug)‘s full profile, request access.

Request a free trial

Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) FAQs

  • Where is Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) headquartered?

    Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) is headquartered in Carlsbad, CA.

  • What industry is Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) in?

    Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug)’s primary industry is Buildings and Property.

  • Is Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) a private or public company?

    Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) is a Private company.

  • What is the current valuation of Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug)?

    The current valuation of Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) is .

  • What is Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug)’s current revenue?

    The current revenue for Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) is .

  • Who are Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug)’s investors?

    Ionis Pharmaceuticals has invested in Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug).

  • When was Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) acquired?

    Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) was acquired on 05-Jun-2015.

  • Who acquired Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug)?

    Isis Pharmaceuticals (License For ISIS-FXIRx, An Experimental Anti-Coagulant Drug) was acquired by Bayer.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »